http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010105024-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d32caab11a2fe55d5d593370cfa098b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6834 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-544 |
| filingDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e822a414666b58a46a5741553e328410 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1626f363887255d62601293ed9f6fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a28cac57848cc0cab901e796642d8f |
| publicationDate | 2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2010105024-A1 |
| titleOfInvention | Rapid test including genetic sequence probe |
| abstract | A rapid test kit may have a genetic probe, and antibody detecting probe or a combination of a genetic probe and an antibody detecting probe disposed within one or more test windows of the test kit. A cellulose filter paper membrane with a flow rate selected in a range of about 0.04 to about 0.4 ml/min/cm 2 is used in one example. The test kit provides for rapid screening for DNA, RNA or fragments of DNA or RNA in a bodily fluid or antibodies indicating exposure to such DNA/RNA. The genetic probe may include single stranded DNA or a fragment of single stranded DNA, such as primer, immobilized on the filter paper, and a single stranded DNA, such as the same or a different primer, conjugated with a marker, such as a nanotube or nanoparticle. For example, a gold nanoparticle or a carbon nanotube may be used as a staining agent by conjugating the gold nanoparticle or the carbon nanotube to a genetic probe, such as a DNA primer capable of binding with a complementary DNA or viral RNA or a fragment of one of these. By comparing contrast or intensity of a test spot to a standard, a viral load may be reported. By comparing a test region using the genetic marker and a test region using an antigen to detect antibodies, a sensitive and specific test may be conducted during use of a vaccine to determine the effectiveness of the vaccine, for example. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017070643-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9777313-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021185357-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014175827-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2802783-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2802079-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2802781-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014030778-A1 |
| priorityDate | 2008-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 532.